Back to company

Afyx Development A/S: Financial statements 2025

CVR: 35839739

Afyx Development A/S (CVR 35839739) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -5,044,782 and a net result of DKK -4,260,251 compared with DKK -6,896,490 the year before. Equity amounted to DKK -7,253,987. The company had 3 employees in the financial year.

Gross Profit
-5,044,782 kr.
Profit/Loss
-4,260,251 kr.
Equity
-7,253,987 kr.
Total Assets
3,710,641 kr.
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--5 mio.-4.3 mio.-7.3 mio.3
2024--8.4 mio.-6.9 mio.-3 mio.1
2023--4.7 mio.-10 mio.2.4 mio.3
2022--8.6 mio.-24.3 mio.-112.3 mio.3
2021--27.4 mio.-35 mio.-88 mio.6

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Afyx Development A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

Afyx Development A/S: The 2024 annual report is outMay 27, 2025

Afyx Development A/S has published its annual report for 2024. Gross profit came to DKK -8,423,909, and the net result was DKK -6,896,490.

Afyx Development A/S appoints new auditorFeb 26, 2025

As of February 26, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Afyx Development A/S.

Auditor steps down at Afyx Development A/SFeb 26, 2025

As of February 26, 2025, GILFELT REVISION REGISTRERET REVISIONSANPARTSSELSKAB has stepped down as auditor of Afyx Development A/S.

Søren Mohrsen Kjær joins the board of Afyx Development A/SFeb 26, 2025

As of February 26, 2025, Søren Mohrsen Kjær has joined the board of directors of Afyx Development A/S.

About Afyx Development A/S

Afyx Development A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Juan Møller-San Pedro. The company is owned by Afyx Therapeutics A/S. The company has 8 employees. In 2025, the company reported a gross profit of DKK -5,044,782 and a net result of DKK -4,260,251 compared with DKK -6,896,490 the year before. Equity amounted to DKK -7,253,987.